New Report Available: Italy Pharmaceuticals & Healthcare Report Q3 2014
BMI View: The drop in SSN pharmaceutical expenditure in 9M13 serves as a warning for the continuation of a fall in spending on medicines for the rest of the year. Our bearish outlook takes into account the government's aim to slash public healthcare costs - hitting drug companies, pharmacies and patients with its cost containment measures. The government aimed to slash public healthcare costs by EUR900mn ( USD 1.2bn) in 2012, EUR1.8bn ( USD 2.4bn) in 2013, EUR2.0bn ( USD...
View full press release